Are There Gender Differences in Starting Protease Inhibitors, HAART, and Disease Progression Despite Equal Access to Care?
- 1 August 2000
- journal article
- letter
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 24 (5) , 475-482
- https://doi.org/10.1097/00042560-200008150-00013
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Survival after diagnosis of AIDS: a prospective observational study of 2625 patientsBMJ, 1997
- Race, Sex, Drug Use, and Progression of Human Immunodeficiency Virus DiseaseNew England Journal of Medicine, 1995
- Differences in progression of HIV infection between men and womenBMJ, 1995
- HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversionBMJ, 1994
- Survival in HIV infection: do sex and category of transmission matter?AIDS, 1994
- Efficacy of zidovudine treatment in homosexual men with AIDS-related complexAIDS, 1994
- Survival differences in European patients with AIDS, 1979-89BMJ, 1994
- Trends in Survival among Persons with Acquired Immunodeficiency Syndrome in New York CityAmerican Journal of Epidemiology, 1994
- Survival and Mortality Patterns of an Acquired Immunodeficiency Syndrome (AIDS) Cohort in New York StateAmerican Journal of Epidemiology, 1993
- Survival with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1987